Henagliflozin API is a pharmaceutical-grade Sodium-Glucose Co-Transporter 2 (SGLT2) inhibitor developed for the treatment of Type 2 Diabetes Mellitus (T2DM). It lowers blood glucose levels by inhibiting glucose reabsorption in the kidneys, promoting urinary glucose excretion and improving glycemic control independently of insulin secretion.
Henagliflozin is designed for once-daily oral administration and may be used alone or in combination with other antidiabetic medications. It has demonstrated effectiveness in improving glycemic control while supporting weight management and cardiovascular risk reduction in appropriate patients.
Swapnroop Drugs and Pharmaceuticals manufactures premium-quality Henagliflozin API under stringent WHO-GMP manufacturing standards. Every batch undergoes comprehensive testing for purity, assay, stability, impurities, and regulatory compliance. Complete documentation including Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), and Technical Data Sheet (TDS) is available.
Henagliflozin API is supplied in pharmaceutical-grade HDPE containers or fiber drums.
Henagliflozin API is used in oral formulations for the treatment of Type 2 Diabetes Mellitus by improving blood glucose control.
Henagliflozin inhibits the SGLT2 transporter in the kidneys, reducing glucose reabsorption and increasing urinary glucose excretion to lower blood sugar levels.
Yes. We provide CoA, MSDS, Technical Data Sheet (TDS), Product Specifications, and complete regulatory documentation.
Yes. We supply Henagliflozin API in commercial quantities with worldwide export support.
Get Bulk Quote via WhatsApp